ARTICLE | Clinical News
Elafin regulatory update
January 14, 2013 8:00 AM UTC
Proteo said FDA granted Orphan Drug designation to Elafin for the treatment of pulmonary arterial hypertension (PAH). Elafin is in preclinical testing for the indication. The natural antagonist of el...